Address	200 Barr Harbor Drive West Conshohocken Pennsylvania 19428 United States
Employees	-
Website	http://www.madrigalpharma.com
Updated	07/08/2019
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.